[HTML][HTML] PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor

A Loupy, SK Ramakrishnan, B Wootla… - The Journal of …, 2012 - Am Soc Clin Investig
A Loupy, SK Ramakrishnan, B Wootla, R Chambrey, R de La Faille, S Bourgeois…
The Journal of clinical investigation, 2012Am Soc Clin Investig
Tight regulation of calcium levels is required for many critical biological functions. The Ca2+-
sensing receptor (CaSR) expressed by parathyroid cells controls blood calcium
concentration by regulating parathyroid hormone (PTH) secretion. However, CaSR is also
expressed in other organs, such as the kidney, but the importance of extraparathyroid CaSR
in calcium metabolism remains unknown. Here, we investigated the role of extraparathyroid
CaSR using thyroparathyroidectomized, PTH-supplemented rats. Chronic inhibition of CaSR …
Tight regulation of calcium levels is required for many critical biological functions. The Ca2+-sensing receptor (CaSR) expressed by parathyroid cells controls blood calcium concentration by regulating parathyroid hormone (PTH) secretion. However, CaSR is also expressed in other organs, such as the kidney, but the importance of extraparathyroid CaSR in calcium metabolism remains unknown. Here, we investigated the role of extraparathyroid CaSR using thyroparathyroidectomized, PTH-supplemented rats. Chronic inhibition of CaSR selectively increased renal tubular calcium absorption and blood calcium concentration independent of PTH secretion change and without altering intestinal calcium absorption. CaSR inhibition increased blood calcium concentration in animals pretreated with a bisphosphonate, indicating that the increase did not result from release of bone calcium. Kidney CaSR was expressed primarily in the thick ascending limb of the loop of Henle (TAL). As measured by in vitro microperfusion of cortical TAL, CaSR inhibitors increased calcium reabsorption and paracellular pathway permeability but did not change NaCl reabsorption. We conclude that CaSR is a direct determinant of blood calcium concentration, independent of PTH, and modulates renal tubular calcium transport in the TAL via the permeability of the paracellular pathway. These findings suggest that CaSR inhibitors may provide a new specific treatment for disorders related to impaired PTH secretion, such as primary hypoparathyroidism.
The Journal of Clinical Investigation